Latest fibrosis Stories
MENLO PARK, Calif., June 25, 2014 /PRNewswire/ -- Virobay, Inc., a clinical stage pharmaceutical company with a broad platform of cathepsin protease inhibitors being developed for the treatment
LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
CHICAGO, June 10, 2014 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) today announced a key partnership with Biogen Idec in support of the PFF Patient Registry.
Renowned health writer documents discovery of modified citrus pectin in her latest book SANTA ROSA, Calif., June 4, 2014 /PRNewswire/ -- One of the nation's leading writers on the
Results from Boehringer Ingelheim, InterMune and IPFnet clinical trials discussed CHICAGO, May 18, 2014 /PRNewswire-USNewswire/ -- WHO: The Pulmonary Fibrosis
Now includes information about InterMune's Expanded Access Program CHICAGO, May 16, 2014 /PRNewswire/ -- The newly launched Pulmonary Fibrosis Foundation Patient Communication Center
Inflammation has long been considered an integral part of the biological process that leads to deadly scarring in idiopathic pulmonary fibrosis.
A discovery by Northwestern Medicine scientists could lead to potential new treatments for breaking the cycle of tissue scarring in people with scleroderma.
CHICAGO, March 27, 2014 /PRNewswire-USNewswire/ -- Patients with pulmonary fibrosis (PF), their caregivers, family members, and health care providers will now be able to access a centralized
LONDON, March 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
- A gift; a largess; a gratuity; a present; a dole.